MariMed Inc. (OTCMKTS:MRMD – Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.07 and traded as high as $0.0773. MariMed shares last traded at $0.0757, with a volume of 6,060,899 shares.
MariMed Stock Performance
The firm’s 50 day simple moving average is $0.07 and its 200-day simple moving average is $0.07. The company has a debt-to-equity ratio of 1.78, a quick ratio of 0.34 and a current ratio of 0.92.
MariMed (OTCMKTS:MRMD – Get Free Report) last released its earnings results on Wednesday, November 11th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01). MariMed had a negative return on equity of 10.71% and a negative net margin of 9.13%.
About MariMed
MariMed, Inc. is a U.S.-based cannabis company that develops, operates and manages licensed cannabis cultivation, processing and dispensary facilities. The company serves both medical and adult-use markets, where permitted by state law, and focuses on producing and distributing cannabis flower, concentrates, edibles, tinctures and other cannabis-infused products. MariMed markets products under brands that have included Betty’s Eddies, Nature’s Heritage, InHouse and Kalm Fusion. Its products are sold through the company’s retail operations and third-party dispensaries in its operating markets.
See Also
- Five stocks we like better than MariMed
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
